医学
乳腺癌
液体活检
仿形(计算机编程)
临床试验
基因组学
基因组
疾病
精密医学
癌症
生物信息学
计算生物学
基因
病理
内科学
遗传学
生物
计算机科学
操作系统
作者
Clayton T. Marcinak,Muhammed Murtaza,Lee G. Wilke
标识
DOI:10.1016/j.suc.2022.08.003
摘要
The cancer genome plays an increasingly large role in the care of patients with breast cancer. Commercially available gene-expression profiling assays are now a part of staging and treatment guidelines, and their use continues to be examined in large-scale studies. With the advent of next-generation sequencing, the cancer genome can now be examined more quickly, less invasively, and in much greater detail. These technologies have led to a more nuanced understanding of molecular pathways, allowing providers to better match patients to clinical trials. Furthermore, a new era of diagnostics based on liquid biopsies is expected to revolutionize disease detection and clinical care.
科研通智能强力驱动
Strongly Powered by AbleSci AI